Anterix (ATEX) Projected to Post Earnings on Tuesday

Anterix (NASDAQ:ATEX) will likely be issuing its Q1 2027 results after the market closes on Tuesday, August 11th. Analysts expect Anterix to announce earnings of ($0.4333) per share and revenue of $2.0020 million for the quarter. Investors are encouraged to explore the company’s upcoming Q1 2027 earning report for the latest details on the call scheduled for Wednesday, August 12, 2026 at 9:00 AM ET.

Anterix Price Performance

NASDAQ ATEX traded up $6.59 on Tuesday, hitting $102.24. 78,948 shares of the company’s stock were exchanged, compared to its average volume of 397,949. The firm’s 50-day moving average price is $87.10 and its two-hundred day moving average price is $55.87. Anterix has a fifty-two week low of $17.58 and a fifty-two week high of $113.00. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of 21.12 and a beta of 0.85.

Wall Street Analysts Forecast Growth

ATEX has been the topic of a number of analyst reports. Weiss Ratings upgraded Anterix from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. Clear Str upgraded shares of Anterix to a “strong-buy” rating in a research report on Monday, July 27th. Wall Street Zen raised shares of Anterix from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. JPMorgan Chase & Co. increased their price target on shares of Anterix from $50.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, July 20th. Finally, B. Riley Financial cut shares of Anterix from a “buy” rating to a “neutral” rating and raised their price objective for the company from $44.00 to $69.00 in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $101.00.

Insider Activity

In other Anterix news, Director Mahvash Yazdi sold 7,000 shares of the business’s stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $80.00, for a total transaction of $560,000.00. Following the sale, the director directly owned 19,407 shares in the company, valued at approximately $1,552,560. The trade was a 26.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Mark Fleischhauer sold 3,500 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $79.83, for a total value of $279,405.00. Following the completion of the sale, the director directly owned 12,769 shares in the company, valued at $1,019,349.27. This trade represents a 21.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 124,109 shares of company stock valued at $10,174,158 in the last 90 days. Insiders own 40.05% of the company’s stock.

Hedge Funds Weigh In On Anterix

Several hedge funds have recently added to or reduced their stakes in the business. Millennium Management LLC boosted its stake in shares of Anterix by 1,153.1% during the fourth quarter. Millennium Management LLC now owns 439,946 shares of the company’s stock valued at $9,604,000 after acquiring an additional 404,838 shares during the last quarter. Beartown Capital Management LLC acquired a new position in Anterix in the 4th quarter valued at about $3,165,000. Marshall Wace LLP lifted its holdings in Anterix by 51.6% in the 3rd quarter. Marshall Wace LLP now owns 286,581 shares of the company’s stock valued at $6,153,000 after purchasing an additional 97,601 shares in the last quarter. Atom Investors LP lifted its holdings in Anterix by 196.9% in the 4th quarter. Atom Investors LP now owns 83,085 shares of the company’s stock valued at $1,814,000 after purchasing an additional 55,097 shares in the last quarter. Finally, Qube Research & Technologies Ltd boosted its stake in shares of Anterix by 33.1% during the 2nd quarter. Qube Research & Technologies Ltd now owns 203,144 shares of the company’s stock worth $5,211,000 after purchasing an additional 50,564 shares during the last quarter. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Anterix Company Profile

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.